• Profile
Close

Contrast-enhanced 18F-FDG-PET/CT for differentiating tumor and radionecrosis in head and neck cancer: Our experience in 37 patients

Clinical Otolaryngology Jul 13, 2018

Meerwein CM, et al. - Researchers conducted a retrospective study on 37 head and neck squamous cell cancer (HNSCC) patients to assess the performance of different (18F) fluoro-deoxy-D-glucose (FDG) positron emission tomography (PET) / computed tomography (CT) parameters for distinguishing radionecrosis and tumor persistence/recurrence. Tumor recurrence/persistence could be identified and radionecrosis could be ruled out with the presence of a permeative growth pattern in HNSCC patients after RT (accuracy: 100%). Radionecrosis was independently predicted with similar high accuracy (accuracy: 99%) by the combination of a low SUVmax, location of the hottest voxel inside bone/cartilage and the presence of a pathological fracture.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay